13 October 2021|2:00 pm - 3:30 pm EDT
Intersection of Substance Use, HIV, and HCV: What Behavioral Health Providers Need to Know
Part 3: Stimulants, HIV, and HCV
Patients co-diagnosed with HIV, hepatitis C virus (HCV), and SUD face unique challenges—and their care challenges providers. Access to medical treatment, substantially disrupted by the COVID-19 pandemic, has further complicated the unique needs of patients with multiple diagnoses.
In this webinar series, experts from the UCLA Integrated Substance Abuse Programs and the Pacific Southwest Addiction Technology Transfer Center will discuss emerging and important SUD, HIV, and viral HCV topics.
